Ngm Biopharmaceuticals, Inc.

Dana Yen Mei Duey

Yan Wang

Wenwu Zhai

Jie Tang

Zhonghao Liu

Yiyuan Yin

Kalyani Mondal

Daniel David Kaplan

Allen James Ebens, Jr

Chia-Ying Kao Lam

Geoffrey William Stone

Jared Martin Higbee

Jr Allen James Ebens

The present disclosure provides binding agents, such as antibodies, that specifically bind ILT2, ILT4, or both ILT2 and ILT4, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.

ILT-binding agents and methods of use thereof

The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising same.

C3-binding agents and methods of use thereof

Anti-C3 antibodies

Growing community of inventors

San Francisco, CA, United States of America

Dana Yen Mei Duey